Replies to post #22075 on BioCurex, Inc.(fka BOCX)

[TheBocx]

I disagree: If the market cataclysm had not taken place, Abbott had taken the product to commercialization and Inverness had made public their intentions to commercialize RECAF and as a consequence BOCX price was $3 you would NOT be complaining about the Smithline deal or anything else, for that matter.

Moro had nothing to do with Abbott not having taken RECAF to the market yet. He cannot tell them what to do, can he? He cannot force Inverness to release information, or breach the confidentiality terms of the contract he signed with them, can he?

You stated: <a CEO that could close some deals instead of negotiating till the technology is obsolete.>

I was under the impression that it was Moro who closed the deal with Abbott, the largest diagnostic company on the planet, and as a consequence of that, the price moved from about $0.50 to over $2. Did many shareholders complain then?

I was also under the impression that it was Moro who closed the deal with Inverness, the largest manufacturer of rapid tests on the planet. How many people complained about that?

Were those deals closed by somebody else? Who?

[Gold Seeker]

Opportunity knocking, even though you have called me multiple names and threatend to sue me, I congratulate you on a well stated post.

It is indeed true that Moro stopped answering questions on the company board and it was not a matter of confidentiality. It was because you and a few others began to ask hard questions.

I wish investors here luck but it certainly went past my risk level last year. Moro thinks my postings have a huge impact on the stock but that is just not true. There are probably close to three thousand investors in this stock and how many of those read this board? Only a small percentage but I hope by presenting some aspects, it helps a few investors with their decisions.

[Gold Seeker]

Opportunity, the CEO acutally works for the BOD or at least that is how it should work. The board is elected by the shareholders or that's how it should work.

In the case of Moro and this company, there are no "checks and balances". Moro just runs everything.

As I mentioned before, shareholders should become active and nominate some directors that have business sense. Dr. Gold should probably be replaced. He is on the scientific advisory committe for what that is worth anyway.

Moro does not own this company. Shareholders do.